News & Updates
Filter by Specialty:
Septal reduction reduces HF readmission, improves survival in oHCM patients
Septal reduction therapies (SRT) lower the readmission rates for heart failure (HF) in Medicare patients with obstructive hypertrophic cardiomyopathy (oHCM), a study has shown.
Septal reduction reduces HF readmission, improves survival in oHCM patients
17 Jan 2023
Higher LDL triglycerides up atherosclerotic CVD risk
Elevated low-density lipoprotein (LDL) triglycerides appear to increase the risk of atherosclerotic cardiovascular disease (ASCVD) and of each ASCVD component, according to a study.
Higher LDL triglycerides up atherosclerotic CVD risk
16 Jan 2023
Higher plasma omega-3 PUFA levels tied to better large arterial elasticity
Increased plasma levels of total and individual omega-3 (n-3) polyunsaturated fatty acids (PUFAs) appear to be associated with higher large artery elasticity (LAE) among persons free of baseline cardiovascular disease (CVD), results of a multi-ethnic study have shown.
Higher plasma omega-3 PUFA levels tied to better large arterial elasticity
08 Jan 2023
Cardiovascular, mortality outcomes in hypertension similar between two thiazide diuretics
The use of chlorthalidone in the treatment of patients with hypertension does not appear to provide better protection against major cardiovascular outcome events or noncancer-related deaths when compared with hydrochlorothiazide, according to a study.
Cardiovascular, mortality outcomes in hypertension similar between two thiazide diuretics
06 Jan 2023
Edoxaban prevents thromboembolism in children with cardiac disease
Edoxaban may be used as an alternative treatment for thromboembolism (TE) prevention in children with cardiac disease showing low rates of clinically relevant bleeding and TE, suggests a study. Some of its advantages include once-daily dosing and infrequent monitoring requirement.